Nutritional Intervention for Sustaining Health (NURISH) Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-64
SponsorUniversity of Illinois at Urbana-Champaign

About this trial

The goal of this clinical trial is to learn if increasing adherence to a Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet pattern improves brain and heart health relative to a healthy control diet in middle-aged adults.The main questions it aims to answer are:

Does the MIND diet improve cognitive performance and heart health relative to a control diet?

Researchers will compare the MIND diet group to a control (a healthy diet that does not match the MIND diet) to see if the MIND provides more benefit to health.

Participants will:

Consume one meal that follows the MIND diet or a control meal every day for 3 months Visit the lab before and after the 3 months of meals for tests. Keep a record of the food they eat during the study.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

45-64 years of age

20/20 or corrected vision

No food allergies or intolerances

Not pregnant, lactating, or have given birth in the past 12 months

Disqualifiers

Non-consent of participant

Above 64 or below 45 years of age

Vision not 20/20 or corrected

Food allergies or intolerances

Trial design

Design model

Parallel

Treatments tested in this trial

  • MIND Diet

    Other intervention

    Daily meals designed to increase adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) dietary pattern.

  • Control Diet

    Other intervention

    Daily meals designed to increase fruit, vegetable, and whole grain intake consistent with a healthy American diet.

Treatment groups

72 Participants
are divided into 2 treatment groups
Group A: MIND DietExperimental treatment 1 intervention
Group B: Control DietActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Attentional Accuracy

Changes in accuracy (%) between groups using a computerized flanker task.

Time frame
12 weeks (Baseline vs Follow-Up)
2

Attentional Reaction Time

Changes in reaction time (ms) between groups using a computerized flanker task.

Time frame
12 weeks (Baseline vs Follow-Up)
3

Attentional Resource Allocation

Changes in P3 event related potential amplitude (microvolts) between groups using a computerized flanker task.

Time frame
12 weeks (Baseline vs Follow-Up)
4

Attentional Processing Speed

Changes in P3 event related potential latency (ms) between groups using a computerized flanker task.

Time frame
12 weeks (Baseline vs Follow-Up)

Secondary outcomes

1

Macular Pigment Optical Density

Changes in Macular Pigment Optical Density (log units) between groups using a macular densitometer.

Time frame
12 weeks (Baseline vs Follow-Up)
2

Visceral Adipose Tissue

Changes in visceral adipose tissue (g) between groups using Dual X-ray Absorptiometry.

Time frame
12 weeks (Baseline vs Follow-Up)

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: